Cargando…

The Study of Tumor Volume as a Prognostic Factor in T Staging System for Non-Small Cell Lung Cancer: An Exploratory Study

BACKGROUND: This study aimed to evaluate T staging system for non-small cell lung cancer (NSCLC) using tumor volume (TV) and other prognostic factors. METHODS: This study included 1309 cases. The TV and greatest tumor diameter (GTD) were semi-automatically measured. The receiver operating characteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Bei, Zhang, Xu, Mo, Yunxian, Chen, Biao, Long, Hao, Rong, Tiehua, Su, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734535/ https://www.ncbi.nlm.nih.gov/pubmed/33297855 http://dx.doi.org/10.1177/1533033820980106

Ejemplares similares

Tumor volume is more reliable to predict nodal metastasis in non-small cell lung cancer of 3.0 cm or less in the greatest tumor diameter
por: Jia, Bei, et al.
Publicado: (2020)

Prediction of Clinical Outcome for All Stages and Multiple Cell Types of Non-small Cell Lung Cancer in Five Countries Using Lung Cancer Prognostic Index()
por: Chen, Tiehua, et al.
Publicado: (2014)

Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study
por: Vaes, Rianne D. W., et al.
Publicado: (2021)

Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study
por: Ankolekar, Anshu, et al.
Publicado: (2021)

Effect of body mass index on survival of patients with stage I non-small cell lung cancer
por: Xie, Hao-Jun, et al.
Publicado: (2017)

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer
por: Sun, Bochen, et al.
Publicado: (2022)

An exploratory study of CT-guided percutaneous radiofrequency ablation for stage I thymoma
por: Dong, Jun, et al.
Publicado: (2019)

Clinicopathological features and outcome of gastric metastases from primary lung cancer: A case report and systematic review
por: HUANG, QINGYUAN, et al.
Publicado: (2015)

Early treatment volume reduction rate as a prognostic factor in patients treated with chemoradiotherapy for limited stage small cell lung cancer
por: Lee, Joohwan, et al.
Publicado: (2015)

Prognostic value of thoracic tumor staging and volume parameters in non-small cell lung cancer patients with synchronous solitary bone metastasis
por: Deng, Kan, et al.
Publicado: (2022)

Chinese Herbal Decoction Based on Syndrome Differentiation as Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer: An Exploratory and Small Prospective Cohort Study
por: Liu, Rui, et al.
Publicado: (2015)

Exploratory Study of a CT Radiomics Model for the Classification of Small Cell Lung Cancer and Non-small-Cell Lung Cancer
por: Liu, Shihe, et al.
Publicado: (2020)

Radiotherapy tumor volume for limited-stage small cell lung cancer: less is more
por: Levy, Antonin, et al.
Publicado: (2020)

Efficacy and Safety of Anlotinib Monotherapy as Third-Line Therapy for Elderly Patients with Non-Small Cell Lung Cancer: A Real-World Exploratory Study
por: Jiang, Hong-Tao, et al.
Publicado: (2021)

Excessive splenic volume is an unfavorable prognostic factor in patients with non-small cell lung cancer treated with chemoradiotherapy
por: Guo, Jianping, et al.
Publicado: (2020)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer
por: Zhang, Xuening, et al.
Publicado: (2021)

The prognostic value of the Naples prognostic score for patients with non-small-cell lung cancer
por: Peng, Si-Min, et al.
Publicado: (2022)

An extracellular matrix-related prognostic and predictive indicator for early-stage non-small cell lung cancer
por: LIM, Su Bin, et al.
Publicado: (2017)

Effectiveness and Safety of Anlotinib Monotherapy for Patients with Extensive-stage Small-Cell Lung Cancer Who Progressed to Chemotherapy: A Real-world Exploratory Study
por: Li, Yonghui, et al.
Publicado: (2022)

Prognostic Factors in Stage III Non-Small-Cell Lung Cancer Patients
por: Urvay, Semiha Elmaci, et al.
Publicado: (2016)

Novel prognostic model for stratifying survival in stage I lung adenocarcinoma patients
por: Liu, Di-Han, et al.
Publicado: (2019)

Comparative efficacy of different combinations of acapella, active cycle of breathing technique, and external diaphragmatic pacing in perioperative patients with lung cancer: a randomised controlled trial
por: Chen, Xiaoxue, et al.
Publicado: (2023)

Prognostic Potential of Nectin Expressions in Colorectal Cancer: An Exploratory Study
por: Kobecki, Jakub, et al.
Publicado: (2023)

Serial blood volume estimation in rabbits using trivalent chromium – An exploratory study
por: Baby, Prathap Moothamadathil, et al.
Publicado: (2019)

Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis
por: Huang, Wei, et al.
Publicado: (2019)

Active cycle of breathing technique may reduce pulmonary complications after esophagectomy: A randomized clinical trial
por: Zhong, Jiudi, et al.
Publicado: (2021)

An Approach to Accelerate Healing and Shorten the Hospital Stay of Patients With Anastomotic Leakage After Esophagectomy: An Explorative Study of Systematic Endoscopic Intervention
por: Zhong, LeQi, et al.
Publicado: (2021)

Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer
por: Boldrini, L, et al.
Publicado: (2005)

Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer
por: Lohinai, Zoltan, et al.
Publicado: (2019)

Prognostic role of TPL2 in early-stage non-small cell lung cancer
por: Boldrini, Laura, et al.
Publicado: (2017)

Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer
por: Boscolo, Alice, et al.
Publicado: (2020)

Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
por: Tatekawa, Kotoha, et al.
Publicado: (2014)

Reduction of tumor volume during radiotherapy in patients with small-cell lung cancer and its prognostic significance
por: Kandler, Christian, et al.
Publicado: (2023)

A Population-Based Study on the Prognostic factors and Efficacy of Adjuvant Chemotherapy in the Postoperative Stage for Patients with Stage IIA Non-Small Cell Lung Cancer
por: Wang, Wei, et al.
Publicado: (2022)

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer
por: Liu, Yi-Zhen, et al.
Publicado: (2016)

Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer
por: Feng, Wen, et al.
Publicado: (2016)

Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort
por: Shen, Fangfang, et al.
Publicado: (2023)

A multi‐omic study reveals BTG2 as a reliable prognostic marker for early‐stage non‐small cell lung cancer
por: Shen, Sipeng, et al.
Publicado: (2018)

The prognostic role of circulating CD8(+) T cell proliferation in patients with untreated extensive stage small cell lung cancer
por: An, Ning, et al.
Publicado: (2019)

The prognostic value of serum albumin–globulin ratio in early-stage non-small cell lung cancer: a retrospective study
por: Wang, Yan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hp0vrpa8855dlco02f52sbhfjd